174 related articles for article (PubMed ID: 16524802)
1. [Inflammatory markers in heart failure].
Ozmen N; Cebeci BS; Kardeşoğlu E
Anadolu Kardiyol Derg; 2006 Mar; 6(1):51-4. PubMed ID: 16524802
[TBL] [Abstract][Full Text] [Related]
2. Increase in anti-inflammatory cytokine levels in chronic heart failure: a measure of treatment success or failure?
Bolger AP; Sharma R
Circulation; 2001 Oct; 104(18):E97. PubMed ID: 11684645
[No Abstract] [Full Text] [Related]
3. [Immunactivation in chronic heart failure. Inflammatory mediators].
Genth-Zotz S; von Haehling S; Blankenberg S
Z Kardiol; 2004; 93 Suppl 4():IV24-30. PubMed ID: 15085363
[TBL] [Abstract][Full Text] [Related]
4. [Markers of coronary damage. From diagnosis to prognosis].
Valgimigli M; Squasi PA; Gaitani S; Arcozzi C; Martano S; Ferrari R
Recenti Prog Med; 2005 Nov; 96(11):566-72. PubMed ID: 16499168
[TBL] [Abstract][Full Text] [Related]
5. Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy.
Glick A; Michowitz Y; Keren G; George J
Isr Med Assoc J; 2006 Jun; 8(6):391-5. PubMed ID: 16833167
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 and tumor necrosis factor-alpha as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide.
Boffa GM; Zaninotto M; Sartor R; Mion M; Berton A; Pasqualetto C; Razzolini R; Plebani M
J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):758-64. PubMed ID: 19553828
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers in heart failure. Does prognostic utility translate to clinical futility?
Maisel A
J Am Coll Cardiol; 2007 Sep; 50(11):1061-3. PubMed ID: 17825715
[No Abstract] [Full Text] [Related]
8. Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure.
Iwaoka M; Obata JE; Abe M; Nakamura T; Kitta Y; Kodama Y; Kawabata K; Takano H; Fujioka D; Saito Y; Kobayashi T; Hasebe H; Kugiyama K
J Card Fail; 2007 May; 13(4):247-53. PubMed ID: 17517342
[TBL] [Abstract][Full Text] [Related]
9. The role of b-type natriuretic peptide in heart failure management.
Newton PJ; Betihavas V; Macdonald P
Aust Crit Care; 2009 Aug; 22(3):117-23. PubMed ID: 19589695
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders.
von Haehling S; Schefold JC; Lainscak M; Doehner W; Anker SD
Heart Fail Clin; 2009 Oct; 5(4):549-60. PubMed ID: 19631179
[TBL] [Abstract][Full Text] [Related]
11. [Biomarkers in heart failure: are they clinically useful?].
Kempf T; Wollert KC
Dtsch Med Wochenschr; 2009 Apr; 134(15):740-6. PubMed ID: 19340752
[No Abstract] [Full Text] [Related]
12. The prognostic value of anemia, right-heart catheterization and neurohormones in chronic heart failure.
Gardner RS; McDonagh TA
Expert Rev Cardiovasc Ther; 2006 Jan; 4(1):51-7. PubMed ID: 16375628
[TBL] [Abstract][Full Text] [Related]
13. [Cytokines and heart failure].
Baumgarten G; Grohe C; Hoeft A; Knuefermann P
Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Apr; 39(4):197-203. PubMed ID: 15098167
[TBL] [Abstract][Full Text] [Related]
14. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
[TBL] [Abstract][Full Text] [Related]
15. Current understanding of biochemical markers in heart failure.
Sato Y; Miyamoto T; Taniguchi R; Nishio Y; Kita T; Fujiwara H; Takatsu Y
Med Sci Monit; 2006 Nov; 12(11):RA252-64. PubMed ID: 17072279
[TBL] [Abstract][Full Text] [Related]
16. [Safe diagnosis in acute phase with T-proBNP. Heart failure and acute coronary syndrome can be identified very early].
Javadzadeh J; Collén AC; Manhem K; Swedberg K
Lakartidningen; 2008 Feb 27-Mar 4; 105(9):616-9. PubMed ID: 18376704
[No Abstract] [Full Text] [Related]
17. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center.
Amir O; Paz H; Ammar R; Yaniv N; Schliamser JE; Lewis BS
Isr Med Assoc J; 2008 Feb; 10(2):109-12. PubMed ID: 18432021
[TBL] [Abstract][Full Text] [Related]
18. Cytokines and myocardial dysfunction: state of the art.
El-Menyar AA
J Card Fail; 2008 Feb; 14(1):61-74. PubMed ID: 18226775
[TBL] [Abstract][Full Text] [Related]
19. Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial.
Staszewsky L; Wong M; Masson S; Barlera S; Carretta E; Maggioni AP; Anand IS; Cohn JN; Tognoni G; Latini R;
J Card Fail; 2007 Dec; 13(10):797-804. PubMed ID: 18068611
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing acute heart failure: the mathematician and the clinician.
Dickstein K
J Am Coll Cardiol; 2009 Oct; 54(16):1522-3. PubMed ID: 19815123
[No Abstract] [Full Text] [Related]
[Next] [New Search]
